Correlation Between DiaMedica Therapeutics and Cassava Sciences
Can any of the company-specific risk be diversified away by investing in both DiaMedica Therapeutics and Cassava Sciences at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining DiaMedica Therapeutics and Cassava Sciences into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between DiaMedica Therapeutics and Cassava Sciences, you can compare the effects of market volatilities on DiaMedica Therapeutics and Cassava Sciences and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in DiaMedica Therapeutics with a short position of Cassava Sciences. Check out your portfolio center. Please also check ongoing floating volatility patterns of DiaMedica Therapeutics and Cassava Sciences.
Diversification Opportunities for DiaMedica Therapeutics and Cassava Sciences
0.27 | Correlation Coefficient |
Modest diversification
The 3 months correlation between DiaMedica and Cassava is 0.27. Overlapping area represents the amount of risk that can be diversified away by holding DiaMedica Therapeutics and Cassava Sciences in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Cassava Sciences and DiaMedica Therapeutics is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on DiaMedica Therapeutics are associated (or correlated) with Cassava Sciences. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Cassava Sciences has no effect on the direction of DiaMedica Therapeutics i.e., DiaMedica Therapeutics and Cassava Sciences go up and down completely randomly.
Pair Corralation between DiaMedica Therapeutics and Cassava Sciences
Given the investment horizon of 90 days DiaMedica Therapeutics is expected to under-perform the Cassava Sciences. But the stock apears to be less risky and, when comparing its historical volatility, DiaMedica Therapeutics is 1.57 times less risky than Cassava Sciences. The stock trades about -0.12 of its potential returns per unit of risk. The Cassava Sciences is currently generating about -0.07 of returns per unit of risk over similar time horizon. If you would invest 240.00 in Cassava Sciences on December 30, 2024 and sell it today you would lose (75.00) from holding Cassava Sciences or give up 31.25% of portfolio value over 90 days.
Time Period | 3 Months [change] |
Direction | Moves Together |
Strength | Very Weak |
Accuracy | 100.0% |
Values | Daily Returns |
DiaMedica Therapeutics vs. Cassava Sciences
Performance |
Timeline |
DiaMedica Therapeutics |
Cassava Sciences |
DiaMedica Therapeutics and Cassava Sciences Volatility Contrast
Predicted Return Density |
Returns |
Pair Trading with DiaMedica Therapeutics and Cassava Sciences
The main advantage of trading using opposite DiaMedica Therapeutics and Cassava Sciences positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if DiaMedica Therapeutics position performs unexpectedly, Cassava Sciences can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Cassava Sciences will offset losses from the drop in Cassava Sciences' long position.DiaMedica Therapeutics vs. Milestone Pharmaceuticals | DiaMedica Therapeutics vs. Seres Therapeutics | DiaMedica Therapeutics vs. Inhibikase Therapeutics | DiaMedica Therapeutics vs. Oncolytics Biotech |
Cassava Sciences vs. Annovis Bio | Cassava Sciences vs. Axsome Therapeutics | Cassava Sciences vs. Reviva Pharmaceuticals Holdings | Cassava Sciences vs. Seres Therapeutics |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Portfolio File Import module to quickly import all of your third-party portfolios from your local drive in csv format.
Other Complementary Tools
Commodity Directory Find actively traded commodities issued by global exchanges | |
Portfolio File Import Quickly import all of your third-party portfolios from your local drive in csv format | |
Money Flow Index Determine momentum by analyzing Money Flow Index and other technical indicators | |
Portfolio Backtesting Avoid under-diversification and over-optimization by backtesting your portfolios | |
Latest Portfolios Quick portfolio dashboard that showcases your latest portfolios |